Clinical Roundup Receiving CAR T therapy sooner may improve lymphoma survival January 07, 2022Vol.48 No.01
Clinical Roundup Relatlimab + Opdivo improves PFS in metastatic melanoma January 07, 2022Vol.48 No.01
Clinical Roundup MD Anderson research links high-fiber diet to improved outcomes in melanoma January 07, 2022Vol.48 No.01
Drugs & Targets FDA clears IND for P-MUC1C-ALLO1, a fully allogeneic CAR T targeting multiple solid tumors January 07, 2022Vol.48 No.01
Drugs & Targets FDA grants Breakthrough Therapy designation for CLN-081 in locally advanced or metastatic EGFR-mutated NSCLC January 07, 2022Vol.48 No.01
Drugs & Targets FDA grants Fast Track designation for Reqorsa with Keytruda in NSCLC January 07, 2022Vol.48 No.01
Drugs & Targets Rain Therapeutics, Roche to collaborate on clinical trial of milademetan combination with anti-PD-L1 immunotherapy for solid tumors January 07, 2022Vol.48 No.01
NCI Sharpless: NCI paylines to drop amid continuing resolution and federal budget uncertainty December 10, 2021Vol.47 No.45By Matthew Bin Han Ong
Capitol Hill Future of Biden’s ARPA-H murky as second CR delays FY22 appropriations December 10, 2021Vol.47 No.45By Alice Tracey
